Arbutus Biopharma Corp
$5.20
+0.00 (+0.00%)
Price as of Aug 25, 2026 market close
Performance
- 1 Month
- +17.9%
- 3 Months
- +12.1%
- YTD
- +8.1%
- 1 Year
- +44.8%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 48.3%
- Largest decline max drawdown, since Aug 2025
- -25.9%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.01
Own ABUS?
See how ABUS contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.